Trial Profile
A trial of rilpivirine with darunavir/ritonavir to study pharmacokinetics & safety in HIV therapy-naïve patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary) ; Darunavir/ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 12 Dec 2015 New trial record